Category Archives: Coronary Heart Diseases

Scheja, L. Continue reading →

Chooi YC, Ding C, Magkos F. The epidemiology of obesity. Continue reading →

Srinagar born and Government Medical College (GMC Srinagar) MBBS pass out and now top Kashmiri American cardiologist Dr Iftikhar J Kullo has been nominated to the National Advisory Council on Human Genome Research (NACHGR) that the US National Institutes of Health (NIH) runs. Continue reading →

Introduction Astragali Radix is prepared from the roots of Astragalus membranaceus (Fisch.) Bunge.1 As a kind of traditional Chinese medicine, Astragali Radix has a wide range of pharmacological effects, especially on cardiovascular diseases, such as coronary heart disease,2 heart failure,3 viral myocarditis,4 and hypertension.5 Astragaloside IV (AS-IV), one of the main active ingredients in A. membranaceus, exerts various protective effects against cardiovascular diseases, such as preventing the endothelial dysfunction of the aortas in streptozotocin-induced diabetic mice,6 ameliorating lead-related cognitive impairments in mice,7 attenuating hypoxia-induced pulmonary vascular remodeling,8 and restoring myocardial infarction-induced cardiac dysfunction.9 Many studies have shown that several mechanisms contribute to the protective effects of AS-IV against the aforementioned diseases. For example, AS-IV can improve oxidative stress,6 induce Nrf2 nuclear translocation,7 regulate the Notch signaling pathway,8 and inhibit apoptosis by inactivating the JNK and p38 signaling pathways.9 In summary, these results suggest that AS-IV exerts multiple effects on preventing cardiovascular diseases through different mechanisms Continue reading →

Give your heart a head start by knowing and reducing your risks Preventive medical advice sometimes feels like its changing as fast as the weather whirling outside your window. And thats especially true when it comes to preventing heart attacks. Continue reading →

The numbers are staggering. One woman dies every minute from cardiovascular disease in the U.S Continue reading →

According to the current analysis of Reports and Data, the globalCoronary Stents marketwas valued at USD 8.30 Billion in 2018 and is expected to reach USD 15.37 Billion by the year 2026 at a CAGR of 7.9%. Stents are small expandable tubes that are used to treat narrowed or weakened arteries. A coronary stent is a small mesh tube that holds open passages in the body such as weak or narrow arteries. Continue reading →

The global cardiovascular diagnostic testing market revenue was US$ 6,876.27 million in 2020. The global cardiovascular diagnostic testing market revenue is forecast to reach US$ 15,430.44 million by 2030, growing at a compound annual growth rate (CAGR) of 8.1% during the forecast period from 2021-2030. Request To Download Sample of This Strategic Report :-https://reportocean.com/industry-verticals/sample-request?report_id=BWCC512 The term cardiovascular diseases (CVDs) refers to a group of conditions related to the heart and blood vessels, including coronary heart disease, cerebrovascular disease, and rheumatic heart disease Continue reading →

Abstract Objective To compare the efficacy of different statin treatments by intensity on levels of non-high density lipoprotein cholesterol (non-HDL-C) for the prevention of cardiovascular disease in people with diabetes. Design Systematic review and network meta-analysis. Data sources Medline, Cochrane Central Register of Controlled Trials, and Embase from inception to 1 December 2021 Continue reading →

Acumen Research and Consulting Acumen Research and Consulting recently published report titled Anastomosis Devices Market - Global Industry Analysis, Market Size, Opportunities and Forecast, 2021-2028 NEW YORK, March 28, 2022 (GLOBE NEWSWIRE) -- The global anastomosis devices market size is estimated to grow a CAGR above 7.1% over the forecast timeframe and reach a market value of around USD 3,822 million by 2028. Continue reading →